Literature DB >> 11923393

Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Franz-Josef Schmitz1, Andreas Beeck, Mirella Perdikouli, Mechthild Boos, Susanne Mayer, Sybille Scheuring, Karl Köhrer, Jan Verhoef, Ad C Fluit.   

Abstract

Of the 419 Moraxella catarrhalis isolates collected during the 1997-1999 European SENTRY surveillance study, 385 (92%) were beta-lactamase positive. Twenty-two (5.7%) produced BRO-2 beta-lactamase. Twenty-one new mutations were found in the putative promoter region of the bro genes. Nineteen percent of all isolates tested were complement sensitive. Resistance to beta-lactams is not linked to the phylogenetic lineages associated with susceptibility to complement.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11923393      PMCID： PMC140350          DOI： 10.1128/JCM.40.4.1546-1548.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  26 in total

1.  Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.

Authors:  S S Richter; P L Winokur; A B Brueggemann; H K Huynh; P R Rhomberg; E M Wingert; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Genetic diversity among strains of Moraxella catarrhalis cultured from the nasopharynx of young and healthy Brazilian, Angolan and Dutch children.

Authors:  B Wolf; M Kools-Sijmons; C Verduin; L C Rey; A Gama; J Roord; J Verhoef; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-10       Impact factor: 3.267

3.  Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.

Authors:  D F Sahm; M E Jones; M L Hickey; D R Diakun; S V Mani; C Thornsberry
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

4.  Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors:  R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Novel beta-lactamase from Branhamella catarrhalis.

Authors:  A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal:  Ann Microbiol (Paris)       Date:  1978-10

6.  Complement resistance in Branhamella (Moraxella) catarrhalis.

Authors:  C Hol; C M Verduin; E van Dijke; J Verhoef; H van Dijk
Journal:  Lancet       Date:  1993-05-15       Impact factor: 79.321

7.  Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?

Authors:  H J Bootsma; P C Aerts; G Posthuma; T Harmsen; J Verhoef; H van Dijk; F R Mooi
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

8.  Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer.

Authors:  H J Bootsma; H van Dijk; P Vauterin; J Verhoef; F R Mooi
Journal:  Mol Microbiol       Date:  2000-04       Impact factor: 3.501

9.  Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits.

Authors:  H J Bootsma; H G van der Heide; S van de Pas; L M Schouls; F R Mooi
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

10.  A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo.

Authors:  M E Helminen; I Maciver; M Paris; J L Latimer; S L Lumbley; L D Cope; G H McCracken; E J Hansen
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226
View more
  10 in total

1.  Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Authors:  Raina T Gergova; Ianko D Iankov; Iana H Haralambieva; Ivan G Mitov
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

2.  Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells.

Authors:  Rachel Balder; Thomas M Krunkosky; Chi Q Nguyen; Lacey Feezel; Eric R Lafontaine
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

3.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Presumed endocarditis caused by BRO beta-lactamase-producing Moraxella lacunata in an infant with Fallot's tetrad.

Authors:  Noriyuki Nagano; Junichi Sato; Christophe Cordevant; Yukiko Nagano; Fumiaki Taguchi; Matsuhisa Inoue
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

5.  Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated In Vitro by Stepwise Selection.

Authors:  Kageto Yamada; Ryoichi Saito; Saori Muto; Machiko Kashiwa; Yoshiko Tamamori; Shingo Fujisaki
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

6.  Moraxella Bacteremia in Cancer Patients.

Authors:  Shamra Zaman; John Greene
Journal:  Cureus       Date:  2021-05-29

7.  Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.

Authors:  Rachel Balder; Teresa L Shaffer; Eric R Lafontaine
Journal:  BMC Microbiol       Date:  2013-06-19       Impact factor: 3.605

8.  Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.

Authors:  Teresa L Shaffer; Rachel Balder; Sean W Buskirk; Robert J Hogan; Eric R Lafontaine
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

9.  Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections.

Authors:  Safia Bader Uddin Shaikh; Zafar Ahmed; Syed Ali Arsalan; Sana Shafiq
Journal:  Infect Drug Resist       Date:  2015-07-31       Impact factor: 4.003

10.  Characterization of antibiotic resistance and host-microbiome interactions in the human upper respiratory tract during influenza infection.

Authors:  Lingdi Zhang; Christian V Forst; Aubree Gordon; Gabrielle Gussin; Adam B Geber; Porfirio J Fernandez; Tao Ding; Lauren Lashua; Minghui Wang; Angel Balmaseda; Richard Bonneau; Bin Zhang; Elodie Ghedin
Journal:  Microbiome       Date:  2020-03-17       Impact factor: 14.650
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.